OCUMENSION THERAPEUTICS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.89 HKD | +0.44% |
|
+3.61% | +3.14% |
| 15/04 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
| 15/04 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 61Cr | - | |||||
| 75TCr | ||||||
| 61TCr | ||||||
| 36TCr | ||||||
| 33TCr | ||||||
| 29TCr |
